July 2nd 2024
Nikhil Khushalani, MD, discusses the benefits and limitations of fixed-dose treatment regimens in patients with unresectable or metastatic melanoma.
May 24th 2023
A panel of skin cancer experts offer closing thoughts on intralesional therapy for treating melanoma and CSCC.
May 17th 2023
An expert panel discusses the use of tumor-directed oncolytic therapies for melanoma and cutaneous squamous cell carcinoma.
A comprehensive overview of treatment approaches for patients with high-risk melanoma.
May 10th 2023
Experts on skin cancer discuss valuable end points for determining successful treatments for patients with metastatic melanoma.
A panel of skin cancer experts share their thoughts on treatment selection for patients with melanoma.
May 3rd 2023
An expert panel analyzes BRAF/MEK dual inhibitor therapy for the treatment of melanoma.
Anna C. Pavlick, DO, discusses factors that impact treatment selection for patients with melanoma.
April 26th 2023
Expert oncologists look to the future of treatment for cutaneous squamous cell carcinoma.
Skin cancer expert Anna C. Pavlick, DO, discusses treatment duration approaches for cutaneous squamous cell carcinoma.
April 19th 2023
Nikhil Khushalani, MD, gives a comprehensive overview of cemiplimab and pembrolizumab for treating CSCC.
Anna C. Pavlick, DO, overviews systemic therapy options for patients with unresectable or metastatic CSCC.
April 12th 2023
Nikhil Khushalani, MD, discusses the multidisciplinary team approach to treating patients with cutaneous squamous cell carcinoma.
Skin cancer experts discuss prognosis and unmet needs in the cutaneous squamous cell carcinoma and melanoma treatment spaces.
March 31st 2023
A panel of skin cancer experts give an overview of cutaneous squamous cell carcinoma and melanoma.
March 15th 2023
A review of current staging systems used to categorize CSCC, particularly those from the American Joint Committee on Cancer and Brigham and Women's Hospital.
Opening their discussion on resectable cutaneous squamous cell carcinoma (CSCC), expert panelists elucidate its current incidence and known risk factors.
November 9th 2022
Nikhil Khushalani, MD, comments on upcoming treatment advances he looks forward to for patients with BCC.
November 2nd 2022
An expert provides a brief overview of basal cell carcinoma (BCC) and reviews currently available treatment options for patients with BCC.
Dr Khushalani discusses challenges faced when treating patients with cSCC and shares advice for fellow colleagues who treat patients with cSCC.